SciTransfer
Organization

ENCORE LAB SL

Spanish technology SME building adaptive sensor and IoT systems, with projects in epilepsy monitoring and autonomous precision farming.

Technology SMEhealthESSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
1
Total EC funding
€687K
Unique partners
60
What they do

Their core work

ENCORE LAB is a Spanish technology SME based in Logroño that builds intelligent monitoring and adaptive embedded systems — software and hardware solutions that sense, process, and respond to real-world conditions autonomously. Their demonstrated work spans two distinct domains: patient safety (a self-adaptive night-time seizure detection and alert system for epilepsy caregivers) and precision agriculture (cloud-connected autonomous farming with cyber-physical systems, livestock monitoring, and farming robots). The common thread across both domains is adaptive sensor intelligence applied in time-critical, real-environment contexts. As a small company that has both led EU projects and joined large research consortia, they appear to operate as a technology developer with end-to-end prototyping capacity.

Core expertise

What they specialise in

Adaptive embedded systems and IoT monitoringprimary
2 projects

Both SEIZSAFE and AFarCloud rely on real-time sensing and adaptive response logic — the core capability that connects an epilepsy alert system and an autonomous farming platform.

Medical device and patient monitoringsecondary
1 project

SEIZSAFE (coordinator, EUR 599,462) was a patient-self-adaptive system for detecting and recording night-time seizures, indicating product-level expertise in health monitoring devices.

1 project

As a participant in AFarCloud, ENCORE LAB contributed to cyber-physical systems for livestock management, crop monitoring, and autonomous farming vehicles.

Autonomous and semi-autonomous vehicles / farming robotsemerging
1 project

AFarCloud keywords include autonomous and semi-autonomous vehicles and farming robots, suggesting capacity in robotic systems beyond pure software.

Evolution & trajectory

How they've shifted over time

Early focus
Patient monitoring, medical IoT
Recent focus
Precision agriculture, autonomous farming systems

ENCORE LAB's first H2020 project (SEIZSAFE, 2016–2019) was entirely focused on health technology — specifically a wearable or ambient patient-monitoring system for epilepsy caregivers, with no recorded keywords pointing to agriculture or robotics. Their second project (AFarCloud, 2018–2021) marks a sharp pivot toward precision agriculture and autonomous cyber-physical systems, with all documented keywords belonging to that domain. Whether this represents a genuine strategic shift toward agri-tech, or simply an opportunistic expansion of their sensor/IoT platform into a new sector, cannot be determined from two projects alone.

ENCORE LAB appears to be moving from health monitoring toward agricultural automation, likely applying the same adaptive sensing platform to a sector with higher commercial scalability — making them a potential partner for future agri-tech or rural IoT projects.

Collaboration profile

How they like to work

Role: active_partnerReach: European13 countries collaborated

ENCORE LAB has acted as both project coordinator (SEIZSAFE, SME Instrument Phase 2) and consortium participant (AFarCloud, RIA). As coordinator on SEIZSAFE, they led an SME-focused innovation project end-to-end, signaling business and project management capacity beyond pure R&D. Their participation in AFarCloud — a large RIA with 60 unique partners across 13 countries — shows they can integrate into complex, multi-partner consortia as a specialist contributor. Their network breadth relative to only two projects is unusually wide, which likely reflects the large AFarCloud consortium rather than sustained partner relationships.

ENCORE LAB has connected with 60 unique consortium partners across 13 countries through just two projects — a network footprint that is large relative to their project volume, almost entirely attributable to the AFarCloud RIA consortium. Their geographic reach is European, though their home base in Logroño (La Rioja, Spain) gives them potential proximity to agriculture-heavy regions in Spain and southern Europe.

Why partner with them

What sets them apart

ENCORE LAB is one of the few Spanish SMEs in the H2020 dataset that has successfully led a health-tech innovation project (as SME Instrument Phase 2 coordinator) while also contributing to a large precision-agriculture RIA — making them a rare cross-domain embedded systems developer with both clinical and agricultural deployment experience. For a consortium builder, this means ENCORE LAB can bring an adaptive sensing platform that has already been pressure-tested in two very different real-world contexts, not just in a lab. Their SME profile also makes them eligible for SME-quota slots and fast-moving innovation actions where large research institutes are overrepresented.

Notable projects

Highlights from their portfolio

  • SEIZSAFE
    ENCORE LAB's largest project (EUR 599,462) and the one where they served as coordinator — a patient-adaptive night-time seizure detection system funded under SME Instrument Phase 2, which is among the most competitive EU SME funding tracks.
  • AFarCloud
    A large-scale RIA bringing together 60+ partners to build cloud-connected autonomous farming infrastructure, giving ENCORE LAB exposure to cyber-physical systems, farming robots, and multi-country agricultural IoT deployment.
Cross-sector capabilities
food & agriculture (precision farming, livestock monitoring)digital & IoT (cyber-physical systems, cloud-connected sensors)transport & robotics (autonomous vehicles, semi-autonomous systems)
Analysis note: Only 2 projects across two unrelated domains (health monitoring and precision agriculture) makes it difficult to establish a coherent expertise core. The absence of keywords for SEIZSAFE limits early-period analysis. The 60-partner network is misleading as a signal of sustained relationships — it reflects one large RIA consortium. Profile should be treated as indicative, not definitive.